Wheeler Bio's $31M In Financing To Support Clinical Drug Substance Mfg. Facility
To build a disruptive CDMO model aimed at changing the paradigm for the gene-to-IND supply chain.
Source: contractpharma.com
Page 4 - Jesse Mccool News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jesse Mccool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jesse Mccool Today - Breaking & Trending Today
Presentation set on 'digital twin' technology | The Journal Record
Dr. Jesse McCool, co-founder and CEO of Wheeler Bio, has been tapped to offer a presentation about “digital twin” technology and how it can be used across multiple industries at a forum planned by the Oklahoma Innovation District set for Jan. 26 at the Harold Hamm Institute of American Energy, 300 NE Ninth St.
Source: journalrecord.com
Behind the Scenes Discussion for Building Transformational Leadership with Life Science Partner Founder and Wheeler Bio CEO and COO
/PRNewswire/ -- In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit...
Source: prnewswire.com
Wheeler Bio Licenses ATUM's Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering
/PRNewswire/ -- Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of...
Source: prnewswire.com
CDMO Wheeler Bio And AE Firm CRB Announce Start Of Construction On New GMP Manufacturing Facility In Oklahoma
Contract Development and Manufacturing Organization (CDMO) Wheeler Bio and CRB – a leading global provider of sustainable...
Source: pharmaceuticalonline.com